| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles; 2 Department of Molecular and Medical Pharmacology; 3 Division of Endocrinology and RCMI Molecular Medicine Core Laboratory at Charles Drew University of Medicine and Science; and 4 Jonsson Comprehensive Cancer Center, Los Angeles, California
Requests for reprints: Shehla Pervin, Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, 13-952 Factor Building, 650 Charles Young Drive, South, Los Angeles, CA 90095. Phone: 310-794-5793; Fax: 310-206-5991; E-mail: spervin{at}mednet.ucla.edu.
Key Words: NO translation PKR cyclin D1 eIF2-
Protein synthesis is a tightly controlled process, and its deregulation plays an important role in tumorigenesis. Protein synthesis remains poorly understood with very few well-identified validated targets for therapeutic purposes. In this study, we use nitric oxide (NO), which suppresses protein synthesis by inactivating eukaryotic initiation factor 2-
(eIF2-
), to examine the mechanism by which low and high oxidative stress inhibits protein synthesis. In breast cancer cells, low NO stress induced heme-regulated inhibitor (HRI) activation, which facilitated gradual decline in short half-life proteins. High NO stress induced HRI and protein kinase R (PKR) activation, leading to a sharp decline in protein synthesis as accessed by a decline in short and long half-life proteins and dramatic morphologic changes. In contrast, human mammary epithelial (HME) and Ras transfected untransformed HME (MCF-10A1 neo N) cells were less susceptible to NO-induced inhibition of protein synthesis and cytostasis. Our results suggest that NO-induced cytostasis in breast cancer cells was due to PKR activation and increased phosphorylation of eIF2-
, whereas the reduced susceptibility of normal mammary epithelial cells to NO could be due to the inaccessibility of PKR, which is bound to inhibitor p58. [Cancer Res 2008;68(12):4862–74]
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |